ADC Therapeutics's total assets for Q1 2026 were $291.50M, a decrease of -9.80% from the previous quarter. ADCT total liabilities were $507.87M for the fiscal quarter, a -0.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.